FDA Approves Updated Labeling for Hemophilia A Treatment Novoeight - Monthly Prescribing Reference

FDA Approves Updated Labeling for Hemophilia A Treatment Novoeight  Monthly Prescribing Reference

The Food and Drug Administration (FDA) has approved updated labeling for Novoeight, a human antihemophilic factor (human blood coagulation factor VIII). S.